New drug may protect kids with cancer from chemo side effects

NCT ID NCT04570423

First seen Oct 31, 2025 · Last updated Jun 15, 2026 · Updated 30 times

Summary

This study tests a drug called eflapegrastim in 40 children with solid tumors or lymphoma who are getting chemotherapy. The drug aims to boost white blood cells, reducing the risk of severe infections. Researchers will check how safe the drug is and how the body processes it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Carolinas Medical Center/ Levine Children's Hospital

    TERMINATED

    Charlotte, North Carolina, 28203, United States

  • Levine Children's Health

    TERMINATED

    Charlotte, North Carolina, 28203, United States

  • New York Medical College

    TERMINATED

    Valhalla, New York, 10595, United States

  • UT MD Anderson Cancer Center

    TERMINATED

    Houston, Texas, 77030, United States

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

Conditions

Explore the condition pages connected to this study.